Argenx SE News and Biotechnology & Immunology Research Updates

735.6
6.60
0.91 %
Daily range
Weekly range
  • Mira Kyivska
  • 01.10.2026
Kura Oncology stock seen rising on leukemia drug sales and pipeline potential
Kura Oncology is drawing renewed investor attention as it shifts further into the commercial stage with an approved leukemia treatment and a broader oncology pipeline. JPMorgan says early sales ...
  • Olga Shendetskaya
  • 28.09.2026
U.S. stocks move on leadership changes, analyst calls and AI developments
Midday trading in U.S. equities is being driven by a mix of executive turnover, broker rating changes and fresh updates across aerospace, biotechnology and artificial intelligence. The biggest ...
  • Daria Chernytska
  • 17.09.2026
Ultragenyx wins U.S. approval for gene therapy in rare disease market
Ultragenyx has secured a key regulatory clearance in the U.S. for a treatment targeting a rare fatal disorder with no approved therapy until now. The decision clears the way for Fayuvi to enter ...